Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045056273> ?p ?o ?g. }
- W2045056273 endingPage "717" @default.
- W2045056273 startingPage "710" @default.
- W2045056273 abstract "IgE-mediated allergic reactions to egg white are a serious health problem and ovomucoid being the dominant egg white allergen has been on focus in the past decade. Engineered hypoallergens with reduced reactivity for IgE antibodies are being examined to modulate the allergic response and develop prophylactic allergen vaccines. In this study, we evaluated the immunomodulatory effect of a genetic variant of the third domain of ovomucoid (GMFA) which showed reduced IgE binding with egg allergic patient's sera in comparison to the native form of the third domain of ovomucoid (DIII) in a murine model system. Balb/c mice were injected intraperitoneally with DIII and GMFA antigens. Allergen-specific serum IgG, IgG1, IgG2a, and IgE responses were evaluated using enzyme-linked immunosorbent assay. Splenocyte cytokine levels in the medium of the cultured cells were examined by ELISA and levels of IL-4, INF-gamma, and IL-12 (p70) cytokines were quantified. Neutralization with anti-IL-12 monoclonal antibody was assayed and cytokine levels with respect to GMFA mutant antigen stimulation were measured. GMFA mutant form was found to have significantly reduced levels of specific IgE when compared to the DIII suggesting a mutation-induced abrogation of the IgE binding epitope in mice. The increase in IgG2a levels in GMFA together with the decline of IgE and IgG1 points to a shift from a Th2 response to a Th1 dominated response. The cytokine profile showed a modulation of anti-allergic Th1 phenotype in GMFA from a proallergic Th2 response observed with DIII. Low levels of IL-4 and increased levels of INF-gamma and IL-12 were observed and anti-IL-12 monoclonal antibody restored the levels of IL-4 and suppressed levels of INF-gamma and IL-12 in the GMFA sensitized group. These results indicate that GMFA has a marked suppressive effect on the allergic response of ovomucoid and caused a shift towards a Th1 pathway, thereby modulating the Th1/Th2 cytokine balance and could be used as a potential hypoallergenic candidate for allergen-immunotherapy in the treatment of egg white allergy." @default.
- W2045056273 created "2016-06-24" @default.
- W2045056273 creator A5002997622 @default.
- W2045056273 creator A5089493057 @default.
- W2045056273 date "2006-04-01" @default.
- W2045056273 modified "2023-09-23" @default.
- W2045056273 title "Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model" @default.
- W2045056273 cites W1554121416 @default.
- W2045056273 cites W1971087390 @default.
- W2045056273 cites W1975184227 @default.
- W2045056273 cites W1978223939 @default.
- W2045056273 cites W1979492370 @default.
- W2045056273 cites W1989807794 @default.
- W2045056273 cites W1993980743 @default.
- W2045056273 cites W2021233744 @default.
- W2045056273 cites W2021399618 @default.
- W2045056273 cites W2041647537 @default.
- W2045056273 cites W2070994664 @default.
- W2045056273 cites W2076364928 @default.
- W2045056273 cites W2078200205 @default.
- W2045056273 cites W2084129498 @default.
- W2045056273 cites W2085793755 @default.
- W2045056273 cites W2089206315 @default.
- W2045056273 cites W2093273436 @default.
- W2045056273 cites W2100837269 @default.
- W2045056273 cites W2130614990 @default.
- W2045056273 cites W2139826328 @default.
- W2045056273 cites W2161153692 @default.
- W2045056273 cites W2170266529 @default.
- W2045056273 cites W2172466148 @default.
- W2045056273 cites W249403745 @default.
- W2045056273 cites W4234332479 @default.
- W2045056273 doi "https://doi.org/10.1016/j.bbrc.2006.01.174" @default.
- W2045056273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16494843" @default.
- W2045056273 hasPublicationYear "2006" @default.
- W2045056273 type Work @default.
- W2045056273 sameAs 2045056273 @default.
- W2045056273 citedByCount "16" @default.
- W2045056273 countsByYear W20450562732013 @default.
- W2045056273 countsByYear W20450562732014 @default.
- W2045056273 countsByYear W20450562732015 @default.
- W2045056273 countsByYear W20450562732016 @default.
- W2045056273 countsByYear W20450562732021 @default.
- W2045056273 countsByYear W20450562732023 @default.
- W2045056273 crossrefType "journal-article" @default.
- W2045056273 hasAuthorship W2045056273A5002997622 @default.
- W2045056273 hasAuthorship W2045056273A5089493057 @default.
- W2045056273 hasConcept C104317684 @default.
- W2045056273 hasConcept C141105273 @default.
- W2045056273 hasConcept C147483822 @default.
- W2045056273 hasConcept C159654299 @default.
- W2045056273 hasConcept C170493617 @default.
- W2045056273 hasConcept C185592680 @default.
- W2045056273 hasConcept C189976730 @default.
- W2045056273 hasConcept C195616568 @default.
- W2045056273 hasConcept C203014093 @default.
- W2045056273 hasConcept C207480886 @default.
- W2045056273 hasConcept C2776217527 @default.
- W2045056273 hasConcept C2776529007 @default.
- W2045056273 hasConcept C2776953665 @default.
- W2045056273 hasConcept C2778484053 @default.
- W2045056273 hasConcept C2778690821 @default.
- W2045056273 hasConcept C2779779143 @default.
- W2045056273 hasConcept C2780510475 @default.
- W2045056273 hasConcept C40767141 @default.
- W2045056273 hasConcept C542903549 @default.
- W2045056273 hasConcept C55493867 @default.
- W2045056273 hasConcept C86803240 @default.
- W2045056273 hasConcept C8891405 @default.
- W2045056273 hasConceptScore W2045056273C104317684 @default.
- W2045056273 hasConceptScore W2045056273C141105273 @default.
- W2045056273 hasConceptScore W2045056273C147483822 @default.
- W2045056273 hasConceptScore W2045056273C159654299 @default.
- W2045056273 hasConceptScore W2045056273C170493617 @default.
- W2045056273 hasConceptScore W2045056273C185592680 @default.
- W2045056273 hasConceptScore W2045056273C189976730 @default.
- W2045056273 hasConceptScore W2045056273C195616568 @default.
- W2045056273 hasConceptScore W2045056273C203014093 @default.
- W2045056273 hasConceptScore W2045056273C207480886 @default.
- W2045056273 hasConceptScore W2045056273C2776217527 @default.
- W2045056273 hasConceptScore W2045056273C2776529007 @default.
- W2045056273 hasConceptScore W2045056273C2776953665 @default.
- W2045056273 hasConceptScore W2045056273C2778484053 @default.
- W2045056273 hasConceptScore W2045056273C2778690821 @default.
- W2045056273 hasConceptScore W2045056273C2779779143 @default.
- W2045056273 hasConceptScore W2045056273C2780510475 @default.
- W2045056273 hasConceptScore W2045056273C40767141 @default.
- W2045056273 hasConceptScore W2045056273C542903549 @default.
- W2045056273 hasConceptScore W2045056273C55493867 @default.
- W2045056273 hasConceptScore W2045056273C86803240 @default.
- W2045056273 hasConceptScore W2045056273C8891405 @default.
- W2045056273 hasIssue "3" @default.
- W2045056273 hasLocation W20450562731 @default.
- W2045056273 hasLocation W20450562732 @default.
- W2045056273 hasOpenAccess W2045056273 @default.
- W2045056273 hasPrimaryLocation W20450562731 @default.
- W2045056273 hasRelatedWork W1655559647 @default.
- W2045056273 hasRelatedWork W2008374044 @default.